HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cherubini, A. Articles by Ferrucci, L. Search for Related Content PubMed Articles by Cherubini, A. Articles by Ferrucci, L.

Low Plasma N-3 Fatty Acids and Dementia in Older Persons: The InCHIANTI Study

¹ Institute of Gerontology and Geriatrics, Department of Clinical and Experimental Medicine, Perugia University, Italy.
² Department of Nutrition and Food Science–Xarxa de Referència en Tecnologia d'Aliments de la Generalitat de Catalunya, Barcelona University, Spain.
³ Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.
⁴ Regional Health Agency of Tuscany, Florence, Italy.
⁵ Laboratory of Clinical Epidemiology, Department of Medicine and Sciences of Aging, University "G. D'Annunzio," Chieti, Italy.
⁶ Geriatric Unit, Azienda Sanitaria Firenze, Florence, Italy.
⁷ Laboratory of Neurosciences, Intramural Research Program, and ⁸ Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, Baltimore, Maryland.

Address correspondence to Antonio Cherubini, MD, PhD, Institute of Gerontology and Geriatrics, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy. E-mail: acherub{at}unipg.it

Background. N-3 fatty acids (FA) have an important role in brain development and function. However, there is conflicting evidence concerning the relationship between n-3 FA and dementia in older persons.

Methods. In the Invecchiare in Chianti (InCHIANTI) study, we measured plasma FA by gas chromatography in 935 community-dwelling older persons randomly extracted from the population of two towns near Florence, Italy. Cognitive impairment was measured using the Mini-Mental Status Examination. Participants who scored 26 underwent a detailed clinical and neuropsychological evaluation. The diagnosis of dementia was based on Diagnostic and Statistical Manual of Mental Disorders, Third Revision (DSM-III-R) criteria. The population was divided in three groups: persons with normal cognitive function, persons with cognitive impairment not demented, and persons with dementia.

Results. After adjustment for age, gender, education, body mass index, weight loss, smoking status, cholesterol and triglycerides levels, daily intake of alcohol, FA and total energy, cardiovascular disease, depression and other FA levels, participants with dementia had significantly lower n-3 FA levels (2.9% vs 3.2%; p <.05), particularly alpha-linolenic acid levels (0.34% vs 0.39%; p <.05), than did participants with normal cognitive function.

Conclusions. Dementia is associated with low plasma n-3 FA relative concentrations. The possibility that higher n-3 FA intake is associated with a lower risk of cognitive impairment should be further investigated in prospective studies.